Cloning, expression, and purification of soluble human interleukin-4 receptor in Streptomyces

被引:12
作者
Zhang, Y
Wang, WC
Li, Y
机构
[1] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China
[2] Peking Union Med Coll, Beijing 100050, Peoples R China
[3] Chinese Acad Sci, Inst Phys, Lab Soft Matter Phys, Beijing 100080, Peoples R China
基金
中国国家自然科学基金;
关键词
sIL-4R; streptomyces lividans; asthma;
D O I
10.1016/j.pep.2004.04.010
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-4 (IL-4) is a pleiotropic cytokine which plays a pivotal role in shaping immune responses and mediating important proinflammatory functions in asthma. This cytokine exerts its biological effects through binding to its receptor (IL-4R) complex, with the alpha chain as the high-affinity binding subunit. Soluble IL-4R (sIL-4R) lacks the transmembrane and cytoplasmic domains, so it cannot induce cellular activation. By acting as a decoy to circulating IL-4 and neutralizing its activity, the high specificity and affinity of sIL-4R make it ideal as an IL-4 antagonist. In this study, a sIL-4R cDNA encoding the extracellular domain of IL-4R alpha chain was cloned into a Streptomyces-Escherichia coli shuttle plasmid pSGLgpp and expressed secretly in Streptomyces lividans TK 24. On SDS-PAGE gel, the expressed sIL-4R protein showed a Mw of 24 kDa, agreeable with the predicted size. The N-terminal sequence of the protein was also determined, confirming its identity and indicating that no degradation occurred at the N-terminus. With DEAE-Sepharose Fast Flow and Superdex HR 75 columns, the protein was purified and used on HPLC analysis, the purity reaching about 90%. The results of the ligand-binding blot and ELISA showed that such protein has biological activity of binding with ligand IL-4. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 22 条
[1]  
ARETZ W, 1989, FEMS MICROBIOL LETT, V65, P31, DOI 10.1016/0378-1097(89)90361-3
[2]   Cytokines in nasal fluids from school children with seasonal allergic rhinitis [J].
Benson, M ;
Strannegard, IL ;
Wennergren, G ;
Strannegard, O .
PEDIATRIC ALLERGY AND IMMUNOLOGY, 1997, 8 (03) :143-149
[3]   Expression and characterization of soluble human erythropoietin receptor made in Streptomyces lividans 66 [J].
Binnie, C ;
Jenish, D ;
Cossar, D ;
Szabo, A ;
Trudeau, D ;
Krygsman, P ;
Malek, LT ;
Stewart, DIH .
PROTEIN EXPRESSION AND PURIFICATION, 1997, 11 (03) :271-278
[4]   Ligand selectivity of 105 kDa and 130 kDa lipoprotein-binding proteins in vascular-smooth-muscle-cell membranes is unique [J].
Bochkov, VN ;
Tkachuk, VA ;
Philippova, MP ;
Stambolsky, DV ;
Buhler, FR ;
Resink, TJ .
BIOCHEMICAL JOURNAL, 1996, 317 :297-304
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]  
CHOL P, 1998, CLIN EXP IMMUNOL, V113, P317
[7]  
COFFMAN RL, 1986, J IMMUNOL, V136, P4538
[8]   SOLUBLE FORMS OF THE HUMAN T-CELL RECEPTOR CD4 ARE EFFICIENTLY EXPRESSED BY STREPTOMYCES-LIVIDANS [J].
FORNWALD, JA ;
DONOVAN, MJ ;
GERBER, R ;
KELLER, J ;
TAYLOR, DP ;
ARCURI, EJ ;
BRAWNER, ME .
BIO-TECHNOLOGY, 1993, 11 (09) :1031-1036
[9]   The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor [J].
Hershey, GKK ;
Friedrich, MF ;
Esswein, LA ;
Thomas, ML ;
Chatila, TA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (24) :1720-1725
[10]   HUMAN INTERLEUKIN-4 RECEPTOR CONFERS BIOLOGICAL RESPONSIVENESS AND DEFINES A NOVEL RECEPTOR SUPERFAMILY [J].
IDZERDA, RL ;
MARCH, CJ ;
MOSLEY, B ;
LYMAN, SD ;
VANDENBOS, T ;
GIMPEL, SD ;
DIN, WS ;
GRABSTEIN, KH ;
WIDMER, MB ;
PARK, LS ;
COSMAN, D ;
BECKMANN, MP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (03) :861-873